Press Releases

2017 | 2016 | 2015 | 2014
E-mail Alerts Receive E-mail Alerts | RSS RSS Feeds
Keyword Search
04/11/17Illumina to Announce First Quarter 2017 Financial Results on Tuesday, April 25, 2017Printer Friendly Version
04/10/17Illumina Launches the VeriSeq™ NIPT Solution in EuropePrinter Friendly Version
04/03/17Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViCPrinter Friendly Version
02/28/17Illumina Announces the iHope Network, an Expansion of Its iHope Philanthropic Clinical Whole Genome Sequencing ProgramPrinter Friendly Version
02/21/17Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care ConferencePrinter Friendly Version
02/20/17Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to IlluminaPrinter Friendly Version
01/31/17Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016Printer Friendly Version
01/30/17Illumina Debuts VeriSeq™ Analysis Software (48 Samples), Optimized Data Analysis for Noninvasive Prenatal TestingPrinter Friendly Version
01/27/17Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy IndustriesPrinter Friendly Version
01/17/17Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Tuesday, January 31, 2017Printer Friendly Version
01/12/17Illumina, NRGene Collaborate to Accelerate Development of New Molecular Breeding Tools for Cattle to Support Global Food ProductionPrinter Friendly Version
01/09/17Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex DiseasesPrinter Friendly Version
01/09/17Illumina Introduces the NovaSeq Series—a New Architecture Designed to Usher in the $100 GenomePrinter Friendly Version
01/09/17Philips and Illumina join forces to offer integrated genomics solutions for oncologyPrinter Friendly Version
01/09/17IBM and Illumina Partner to Standardize Genomic Data InterpretationPrinter Friendly Version
01/05/17GRAIL Plans to Raise in Excess of $1B in Series B FundingPrinter Friendly Version
01/03/17Illumina Taps Garret Hampton, One of the World’s Leading Clinical Genomics Experts, to Head its Clinical Genomics UnitPrinter Friendly Version